INTEGRATED BIOPHARMA INC (INBP) Operating cash flow 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.1MFY2025 · since FY2016: -$594,000 → $2.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1M | +119.0% |
| FY2024 | $943,000 | -23.5% |
| FY2023 | $1.2M | -69.9% |
| FY2022 | $4.1M | +34.1% |
| FY2021 | $3.0M | +127.8% |
| FY2020 | $1.3M | +308.2% |
| FY2019 | $328,000 | -71.9% |
| FY2018 | $1.2M | +194.2% |
| FY2017 | $397,000 | +166.8% |
| FY2016 | -$594,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice